Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock
10:51am, Monday, 06'th May 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run?
10:16am, Monday, 06'th May 2024
United Therapeutics (UTHR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
01:01pm, Thursday, 02'nd May 2024
United Therapeutics' (UTHR) first-quarter 2024 earnings and sales beat estimates. Tyvaso sales continue to drive the company's top line.
United Therapeutics Corporation (UTHR) Q1 2024 Earnings Call Transcript
02:46pm, Wednesday, 01'st May 2024
United Therapeutics Corporation (NASDAQ:UTHR ) Q1 2024 Earnings Conference Call May 1, 2024 9:00 AM ET Company Participants Dewey Steadman - Head of Investor Relations Martine Rothblatt - Chairperson
Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key Metrics
10:35am, Wednesday, 01'st May 2024
Although the revenue and EPS for United Therapeutics (UTHR) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
06:30am, Wednesday, 01'st May 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter
What Makes United Therapeutics (UTHR) a New Buy Stock
01:01pm, Monday, 29'th Apr 2024
United Therapeutics (UTHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney Transplant
02:02pm, Friday, 26'th Apr 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Please replace the photo for release dated April 24, 2024 with the accompanying corrected photo. The release reads: UNITED THERAPEUT
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
01:16pm, Wednesday, 24'th Apr 2024
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?
11:07am, Wednesday, 24'th Apr 2024
United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
United Therapeutics Announces World's First Successful Xenothymokidney Transplant
09:00am, Wednesday, 24'th Apr 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the world's first successful transplan
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
07:00am, Wednesday, 24'th Apr 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its first quarter 2024 financial results before
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its commer
3 Underappreciated Healthcare Stocks to Buy Now: April 2024
08:02pm, Wednesday, 03'rd Apr 2024
The healthcare sector is a constant source of innovation and growth. Yet, even amidst the spotlight on industry giants, a realm of underappreciated gems still exists.
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
07:00am, Tuesday, 26'th Mar 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the online availability of a review ma
